β¨ Medicines Distribution Consent
2426
NEW ZEALAND GAZETTE
No. 101
NZ Sponsor: Pacific Pharmaceuticals Limited.
Manufacturer(s): Alcon Couvreur SA, Puurs, Belgium.
Product: Primelle.
Active Ingredient(s): Oestradiol 2 mg.
Norethisterone acetate 1 mg.
Dosage Form: Film coated tablet.
NZ Sponsor: Schering (NZ) Limited.
Manufacturer(s): Schering AG, Wedding Plant, Berlin, Germany.
Product: Sifrol.
Active Ingredient(s): Pramipexole dihydrochloride (monohydrate) 1 mg.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.
Pharmacia & Upjohn Caribe Inc, Arecibo, Puerto Rico.
Product: Sifrol.
Active Ingredient(s): Pramipexole dihydrochloride (monohydrate) 1.25 mg.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.
Pharmacia & Upjohn Caribe Inc, Arecibo2, Puerto Rico.
Product: Sifrol.
Active Ingredient(s): Pramipexole dihydrochloride (monohydrate) 1.5 mg.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.
Pharmacia & Upjohn Caribe Inc, Arecibo, Puerto Rico.
Product: Sifrol.
Active Ingredient(s): Pramipexole dihydrochloride (monohydrate) 125 Β΅g.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.
Pharmacia & Upjohn Caribe Inc, Arecibo, Puerto Rico.
Product: Sifrol.
Active Ingredient(s): Pramipexole dihydrochloride (monohydrate) 250 Β΅g.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.
Pharmacia & Upjohn Caribe Inc, Arecibo, Puerto Rico.
Dated this 18th day of August 1999.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
g06110
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the act and are set out in the Schedule hereto:
Schedule
Product: Ciproxin.
Active Ingredient(s): Ciprofloxacin lactate 2 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer AG, Leverkusen, Germany.
Product: Ciproxin.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 101
NZLII —
NZ Gazette 1999, No 101
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare18 August 1999
Medicines Act 1981, New Medicine, Distribution Consent, Tablets, Film coated
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines Act 1981, Changed Medicine, Distribution Consent, Solution for injection